Recombinant Carcinoembryonic Antigen (VAng-Cr3880)
Recombinant Carcinoembryonic Antigen, Host/Source: Mammalian Cell Expression System. The purity is> 95% by SDS-PAGE.
Datasheet
Specifications
Source
Mammalian Cell Expression System
Target
CEA
Type
Tumor Antigens
Applications
Immunogen, Controls.
Formulation
10 mM Phosphate Buffered Saline, pH 7.4.
Purity
> 95% pure by SDS-PAGE.
Storage
Store at ≤-20°C.
Antigen Information
Introduction
CEA is a member of the carcinoembryonic antigen family. It plays a role in cell adhesion, intracellular signaling and tumor progression. It mediates homophilic and heterophilic cell adhesion with other carcinoembryonic antigen-related cell adhesion molecules. The protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. Its gene is present in a CEA family on chromosome 19. Alternative splicing results in multiple transcript variants.
Alternative Names
CEACAM5
Related Product
All of our products can only be used for research purposes. These vaccine ingredients CANNOT be used directly on humans or animals.
